Objective Metabolic syndrome (MetS) is a constellation of metabolic disturbances and is a risk factor for cardiovascular disease (CVD). Patients with CKD are already exposed to high CVD risk and presence of MetS further deteriorates the situation increasing both cost and mortality. So, this study aims to find out MetS in Nepalese individuals with CKD. Methods 250 CKD (102 females & 148 males) patients defined by NKF-KDOQI guideline not undergoing dialysis were recruited. Blood Pressure and waist circumference were measured while fasting blood samples were analyzed for Triglyceride, HDL & Glucose. MetS was defined by International Diabetic Federation (IDF) guideline. Glomerular filtration Rate (GFR) was estimated by revised MDRD formula. Results Among participants 45.2% had MetS. MetS was prevalent more in females (55.9%) than males (37.8%). Severity of CKD had positive correlation with components of metS which include hypertrigliceridemia (r = 0.08, P = 0.377), low HDL(r = 0.09, P = 0.348), hypertension (r = 0.21, P = 0.02), abdominal adiposity (r = 0.31, P = 0.007) and fasting hyperglycemia (r = 0.04, P = 0.455). 60.8 % of the participants were hypertensive, 52.4% had low HDL, 50.0% had hypetryglyceridemia, 35.2% were diabetic, abdominal obesity was present in 57.2% and 19.2 % were overweight. There was similar prevalence of MetS in three stages of CKD. There was a significant association between the participants’ lifestyle factors and the prevalence of MetS (P = 0.01). Conclusion MetS is prevalent in nearly half of CKD patients. CKD progression has positive correlation with components of MetS.